The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Sometimes, they just put it off, said Dr. Antoine Pham, an internal medicine doctor with Thrive Medical. He has started ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

Carolina Panthers’ former linebacker Dean Wells has died after a two-year battle with cancer. He was 54. Wells, who played in ...

Shift your mindset and unlock your body's potential for better health. See how a small mental change can lead to big results.

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

Arvinas' ARV-102 reduced LRRK2 protein in a Phase 1 trial, showing promising safety and pharmacodynamic outcomes for ...

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

"The people who were answering our questions are just gone,” City Health Commissioner Michael Totoraitis said in an interview ...

A faint line on a pregnancy test can be confusing. Learn what it might mean, when to retest, and how to manage the wait for ...

Many Americans don't know their blood type, but that knowledge can actually tip you off about your risk for certain medical ...